BAFNA PHARMACEUTICALS LTD (BAFNAPH)

NSE: ₹160.31
BSE: ₹162.50
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Change in Directorate

Intimation for retirement of Mr. Navin Kumar (DIN: 08778662) as an Independent Director of the Company upon completion of his first term, with effect from close of business hours on June 22, 2026.

2026-06-22 16:40:42
Announcement under Regulation 30 (LODR)-Retirement

Intimation for retirement of Mr. Navin Kumar (DIN: 08778662) as an Independent Director of the Company upon completion of his first term, with effect from close of business hours on June 22, 2026.

2026-06-22 16:35:09
Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication for the Audited Financial Results of the Company for the Quarter & Year ended March 31, 2026 as published in "Financial Express" and "Makkal Kural" on May 31, 2026.

2026-06-01 13:28:20
Audited Financial Results For Quarter And Year Ended March 31, 2026

We herewith enclose the Audited Financial Results of the Company along with the Statutory Auditor's Report for the Quarter and Year ended March 31, 2026, as approved by the Board of Directors of the Company at its meeting held on May 29, 2026.

2026-05-29 18:54:52
Board Meeting Outcome for Outcome Of The Board Meeting Held On May 29, 2026

We hereby inform you that the Board of Directors in their meeting held on May 29, 2026 inter-alia considered and approved the Audited Financial Results of the Company along with the Auditor’s Report issued by the Statutory Auditor’s of the Company, for the Quarter and Year ended March 31, 2026.

2026-05-29 18:39:31
Board Meeting Intimation for Meeting Scheduled On May 29, 2026

the Audited Financial Results for the Quarter and Year ended March 31, 2026.

2026-05-21 17:58:45
Clarification On Price Movement

We hereby submit our response to the Clarification sought by the Stock Exchange regarding the movement in the Share Price of the Company.

2026-04-15 10:48:07
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of SEBi (DP) Regulations, 2018 for the Quarter ended March 31, 2026.

2026-04-13 15:45:38
Board Meeting Outcome for Outcome For Board Meeting Held On 27/03/2026

The Board of Directors of the Company in the Meeting held on March 27, 2026 has inter-alia considered and approved: (i) The appointment of M/s. K. S. Rao & Co., Chartered Accountants, Chennai as the Internal Auditor of the Company for the Financial Year 2026-2027; (ii) The appointment of M/s. N. Sivashankaran & Co., Cost Accountants, Chennai as the Cost Auditor of the Company for the Financial Year 2026-2027.

2026-03-27 13:12:24

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 41.95 40.68 28.44 41.40 33.29 40.32 33.19 39.06 34.62 35.47 38.29 42.24
YOY Revenue Growth % 147.81% 85.23% -16.88% -2% -20.65% -0.87% 16.68% -5.65% 4.02% -12.04% 15.36% 8.14%
Other Income 1.87 0.16 0.98 0.52 0.51 1.02 0.19 1.03 0.60 1.18 1.22 1.76
Total Income 43.82 40.84 29.42 41.91 33.79 41.35 33.38 40.09 35.22 36.65 39.51 44.00
Total Expenses + 37.47 38.35 32.36 40.46 34.17 38.73 32.42 36.99 31.83 33.52 37.67 41.38
Cost of Materials Consumed 19.56 19.67 16.00 23.79 18.37 21.82 16.87 17.43 17.56 18.56 24.00 21.39
Employee Benefit Expense 4.27 4.85 4.53 5.38 5.14 5.06 5.26 5.58 5.64 5.49 5.35 5.44
Other Expenses 8.69 8.32 7.52 11.07 7.10 9.68 7.12 8.82 6.58 7.63 7.68 8.89
Operating Profit 4.48 2.32 -3.92 0.94 -0.88 1.60 0.77 2.07 2.79 1.95 0.62 0.86
OPM % 10.7% 5.7% -13.8% 2.3% -2.7% 4% 2.3% 5.3% 8.1% 5.5% 1.6% 2%
Profit Before Tax + 6.35 2.48 -2.94 1.46 -0.72 2.62 0.95 1.31 3.39 3.12 1.84 2.62
Tax Expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.13
Tax % 0% 0% - 0% - 0% 0% 0% 0% 0% 0% -4.9%
Profit After Tax 6.35 2.48 -2.94 1.46 -0.72 2.62 0.95 1.31 3.39 3.12 1.84 2.75
EPS (Basic) 2.68 1.05 -1.24 0.62 -0.31 1.11 0.40 0.55 1.43 1.32 0.78 1.16

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 150.62 145.86 152.47 115.35 85.14 71.22 42.47
YOY Revenue Growth % 3.26% -4.33% 32.18% 35.48% 19.55% 67.68% -
Other Income 4.76 2.74 3.52 3.27 2.10 0.75 0.26
Total Income 155.37 148.60 155.99 118.62 87.24 71.97 42.73
Total Expenses + 144.40 142.30 148.64 107.01 79.93 66.14 44.46
Cost of Materials Consumed 82.14 74.49 79.01 59.57 53.06 42.51 30.24
Employee Benefit Expense 21.92 21.03 19.03 15.87 14.50 11.98 10.25
Other Expenses 30.78 32.72 35.60 20.70 7.86 3.48 3.97
Operating Profit 6.21 3.56 3.83 8.34 5.21 5.08 -1.99
OPM % 4.1% 2.4% 2.5% 7.2% 6.1% 7.1% -4.7%
Profit Before Exceptional 10.97 6.30 7.35 11.62 7.31 5.83 -1.88
Exceptional Items 0.00 -2.15 0.00 0.00 -2.16 0.00 -23.33
Profit Before Tax + 10.97 4.15 7.35 11.62 5.15 5.83 -25.20
Tax Expense -0.13 0.00 0.00 0.28 0.00 0.00 0.00
Tax % -1.2% 0% 0% 2.4% 0% 0% -
Profit After Tax 11.10 4.15 7.35 11.34 5.15 5.83 -25.20
EPS (Basic) 4.69 1.76 3.11 4.86 4.34 2.46 -106.54

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 85.88 66.90 53.21 42.27 38.85 36.80 0.00
Property, Plant & Equipment 81.79 58.78 40.21 40.23 38.85 35.97 0.00
Capital Work in Progress 3.13 7.31 10.50 1.50 0.00 0.83 0.00
Non-Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current Assets + 89.65 84.73 94.47 87.31 51.40 49.67 0.00
Inventories 28.90 28.09 29.64 22.22 20.28 15.44 0.00
Trade Receivables 43.93 40.17 45.39 41.15 14.78 9.56 0.00
Cash and Cash Equivalents 2.02 3.43 1.40 7.81 0.00 0.00 0.00
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 96.15 84.81 80.84 73.45 62.88 56.77 0.00
Equity Share Capital 23.66 23.66 23.66 23.66 23.66 23.66 0.00
Other Equity 72.49 61.15 57.18 49.80 39.22 33.11 0.00
Non-Current Liabilities 22.19 16.42 12.76 9.65 10.97 5.39 0.00
Current Liabilities 57.19 51.85 54.08 46.48 16.39 24.31 0.00
Total Liabilities 79.38 68.27 66.84 56.13 27.36 29.69 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 15.37 22.14 9.48 4.95 6.53 -8.64 0.00
Cash from Investing Activities -22.40 -21.16 -15.05 -7.49 -4.54 6.13 0.00
Cash from Financing Activities 5.62 1.06 -0.85 10.18 -3.62 12.37 0.00
Net Increase/Decrease in Cash -1.41 2.04 -6.41 7.64 -1.63 10.28 0.00